| mRNA |
CD-437 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-08 |
| mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
5e-08 |
| mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
4e-07 |
| mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
4e-07 |
| mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
1e-06 |
| mRNA |
RG-108 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-06 |
| mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
2e-06 |
| mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
5e-06 |
| mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
9e-06 |
| mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
-0.21 |
2e-05 |